GenomSys is a technology company.
GenomSys has raised $9.0M across 1 funding round.
GenomSys has raised $9.0M in total across 1 funding round.
GenomSys SA is a Swiss health software company founded in 2016, specializing in tools for genomic data management and analysis to advance personalized medicine.[1][2][5] It develops enterprise-grade solutions based on the ISO/IEC 23092 MPEG-G standard—which it significantly contributed to create—for compressing, storing, sharing, and analyzing genomic data, reducing storage needs by up to 70%, speeding access, and ensuring interoperability and security.[1][2][4][5] The company serves genomic laboratories, healthcare organizations, and precision medicine applications with products like the GenomSys MPEG-G Tool Kit and the CE-marked GenomSys Variant Analyzer, addressing challenges from exploding data volumes due to falling sequencing costs.[3][5][6] Growth includes a CHF 9.3 million Series A round in 2019 and expansion via an Italian subsidiary in Milan in December 2024.[3][5]
GenomSys was founded in 2016 in Switzerland by a team of experienced engineers and bioinformaticians, including co-founder Claudio Alberti, who identified inefficiencies in legacy text-based genomic data formats amid the genomics data explosion.[1][3][5] The idea emerged from collaborations with institutions like Vital-IT (Swiss Institute of Bioinformatics), EPFL, and high-performance computing centers to develop efficient compression, storage, and manipulation tools inspired by digital media standards.[2] A pivotal moment came with leading the development and 2020 publication of the ISO MPEG-G standard—"the MP3 for genomic data"—enabling selective access, native encryption, and dramatic size reductions.[1][2][5] Early traction built through ISO standardization efforts, a 2019 CHF 9.3 million Series A from investors like Elysia Capital, CE-marked product launches, and partnerships such as with Philips and SysMeta IT.[3][5][6]
GenomSys rides the precision medicine wave, where next-generation sequencing costs drop faster than Moore's Law, generating massive data volumes that strain storage, analysis, and sharing.[2][3] Its MPEG-G standard tackles format proliferation and interoperability barriers, enabling an ecosystem of secure, efficient tools as genomics shifts mainstream for diagnostics and treatments.[1][3] Market forces like rising whole-genome sequencing adoption and data privacy regulations (e.g., GDPR) favor its compressed, encrypted format, while falling sequencing costs amplify demand for scalable solutions.[2][4] By standardizing genomic data like MP3 did for audio, GenomSys influences the ecosystem, accelerating lab innovation, personal devices access, and collaborations with giants like Philips, positioning Switzerland as a genomics hub.[3][5][6]
GenomSys is poised to dominate genomic data infrastructure as personalized medicine scales, with its Milan development center (launched December 2024) fueling European expansion and new tools.[5] Trends like AI-driven analysis, mobile genomics, and global data sharing will amplify MPEG-G adoption, potentially capturing market share in a sector projected to explode with sequencing affordability.[2][6] Its influence may evolve from standard-setter to platform leader, powering ecosystem-wide apps if it secures more partnerships and regulatory wins—tying back to its origins in taming genomic data chaos for everyday precision medicine.[1][3]
GenomSys has raised $9.0M in total across 1 funding round.
GenomSys's investors include Astia, Courtney Robinson, Dolby Family Ventures, Gotham Gal Ventures, Joe Kraus, Illuminate Ventures, Kin Ventures, Norwest Venture Partners, Susa Ventures.
GenomSys has raised $9.0M across 1 funding round. Most recently, it raised $9.0M Series A in September 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2019 | $9.0M Series A | Astia, Courtney Robinson, Dolby Family Ventures, Gotham Gal Ventures, Joe Kraus, Illuminate Ventures, Kin Ventures, Norwest Venture Partners, Susa Ventures |